Safety and Immunogenicity of a Fully Glycosylated Recombinant gp160 Human Immunodeficiency Virus Type 1 Vaccine in Subjects at Low Risk of Infection

Autor:	Belshe, Robert B., Clements, Mary Lou, Dolin, Raphael, Graham, Barney S., McElrath, Julie, Gorse, Geoffrey J., Schwartz, David, Keefer, Michael C., Wright, Peter, Corey, Lawrence, Bolognesi, Dani P., Matthews, Thomas J., Stablein, Donald M., O'Brien, Fereshteh S., Eibl, Martha, Dorner, Friedrich, Koff, Wayne
Zdroj:	The Journal of Infectious Diseases, 1993 Dec 01. 168(6), 1387-1395.
Databáze:	JSTOR Journals
Externí odkaz:	https://www.jstor.org/stable/30113687 Zobrazit plný text záznamu